PFBT
HUMA icon

Parkside Financial Bank & Trust’s Humacyte HUMA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$742 Buy
+950
New +$880 ﹤0.01% 2507
2025
Q2 		– Sell
-120
Closed -$204 – 2858
2025
Q1 		$204 Buy
+120
New +$451 ﹤0.01% 2677

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parkside Financial Bank & Trust's HUMA Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in Humacyte (HUMA) in Q2 2026: 950 shares worth $742. The stake represents ﹤0.01% of the portfolio and ranks #2507 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in HUMA as recently as Q1 2025.

Parkside Financial Bank & Trust first reported a position in HUMA in Q1 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Parkside Financial Bank & Trust held 950 shares of Humacyte worth $742 as of Q2 2026.
  • Humacyte was a new Parkside Financial Bank & Trust position in Q2 2026.
  • Humacyte made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2507 holding.
  • Parkside Financial Bank & Trust first reported a position in Humacyte in Q1 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.